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SUBNORMAL serum zinc levels have been observed in a number of neoplastic
diseases including leukaemia (Vikbladh, 1951), Hodgkin's disease (Auerbach,
1965), bronchial carcinoma (Davies, Musa and Dormandy, 1968) and a variety
of other carcinomas and sarcomas (Vikbladh, 1951; Wolff, 1956). By contrast,
elevated serum zinc values appear to be an unusual feature in human malignancy,
although Addink and Frank (1959) have stated that tumours arising in zinc-rich
tissues are associated with high blood zinc levels. Since normal human liver
tissue contains relatively large quantities of zinc (Olson, Heggen, Edwards and
Gorham, 1954), it is ofinterest that elevated serum zinc values have been reported
in 12 patients suffering from primary liver cancer (Karlinsky and Roomere, 1967).
As this tumour is not uncommon in the Southern African Bantu (Berman,
1951; Higginson and Oettle, 1957; Becker and Chatgidakis, 1961), zinc determina-
tions have been performed on the sera of 31 Bantu patients with hepatocellular
carcinoma in an attempt to confirm this observation.
PATIENTS
Serum was obtained from 40 Bantu controls and 31 Bantu males with histo-
logically proven (liver biopsy) malignant hepatomas. The controls were selected
at random from patients convalescing from a variety of medical disorders (not
directly or indirectly involving the liver) and from individuals attending a venereal
diseases clinic (with a provisional diagnosis ofprimary syphilis or gonorrhoea) but
who were otherwise well. Medication in the latter group consisted only of peni-
cillin injections. In particular, no zinc or arsenic containing preparations were
administered or applied to the skin. All 71 were young or middle-aged adult
males; in white subjects no significant change in plasma zinc values attributable
to age has been demonstrated between the years of 20 and 60 (Davies, Musa and
Dormandy, 1968). Many of the hepatoma cases had received cytotoxic therapy
(with a variety of drugs) and a few had been treated with radiation therapy.
METHODS
Six to 8 ml. of venous blood were collected by venepuncture (using all-glass
syringes with disposable needles) and transferred immediately into stoppered
glass tubes. After standing for 121 hours at 370 C. the tubes were centrifuged
(3000 r.p.m. for 15 minutes) and 2 ml. of the supernatant serum pipetted into
125 ml. tallPyrex beakers fordigestion using a mixture of5 ml. nitric acid and 2 ml.
perchloric acid. The serum-acid mixture was covered and gently heated in a fume
cupboard until all organic matter was destroyed leaving only a few drops ofSERUM ZINC IN HEPATOCELLULAR CARCINOMA
residual liquid. This residue was diluted to 10 ml. in a volumetric flask for
subsequent zinc measurement. Zinc assay was performed on a Techtron AA4
atomic absorption spectrophotometer using a standard of pure zinc metal dis-
solved in nitric acid. Three separate aliquots of serum digest were measured,
together with duplicate reagent blanks which were taken through the digestion
procedure since even A.R. grade reagents contained detectable zinc contamination.
All glassware used was decontaminated with hot aqua regia followed by thorough
rinsing with distilled water. The instrument setting were as follows:
Wavelength: 2139 A. Slit Width: 300 microns.
Air pressure: 15 psi. Lamp Current: 6 mA.
Acetylene Flow: setting + 4. Burner: AB-41.
Serum samples showing evidence ofhaemolysis after centrifugation were discarded.
None of the blood samples were collected less than 1 hour postprandially.
RESULTS
The serum zinc values found in the Bantu patients with malignant hepatoma
and the controls are shown in Table I and Fig. 1. Statistical analysis ofthe values
in the two groups indicate that the difference in the serum zinc values is not
significant. No correlation was noted between serum zinc levels and any therapy
administered to the cancer patients.
TABLE I. Serum Zinc Levels in the Controls and Hepatoma Patients
Serum zinc (,ug.%)
Group No. cases Range Mean S.D.
Controls . 40 59-183 . 1005 29 -2
Hepatomas . 31 . 68-360 . 139*0 65- 5
DISCUSSION
Use of the atomic absorption spectrophotometer has greatly simplified
accurate measurement ofzinc in blood (Prasad, Oberleas and Halstead, 1966). By
this technique normal plasma zinc levels are in the region of 100 4ag.% (Prasad,
Oberleas and Halstead, 1966; Davies, Musa and Dormandy, 1968). The results
obtained in the present series indicate that the mean serum zinc level of healthy
South African Bantu males closely approximates the plasma values reported for
Caucasians in other countries.
We have been unable to substantiate the finding of elevated serum zinc
concentrations in association with malignant hepatoma reported by Karlinsky
and Roomere (1967). All but four of the serum zinc levels fall within the range
of the control group. On a hypothetical basis there appears to be no reason to
anticipate increased serum zinc levels in hepatocellular carcinoma, for while it is
known that normal liver tissue contains considerable amounts of zinc (Olson,
Heggen, Edwards and Gorham, 1954), Butt and Higginson (1957) have found
mean hepatic zinc to be subnormal in Bantu cirrhotics. Local epidemiological
studies have established that between 80 and 100% of hepatomas in the South
African Bantu develop in such cirrhotic livers (Berman, 1951; Higginson, 1956;
Becker and Chatgidakis, 1961). Low plasma zinc is a notable feature of alcoholic
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FIG. .---Shows the individual serum zinc levels in the 40 controls and 31 hepatoma cases.
cirrhosis (Vallee, Wacker, Bartholomay and Robin, 1956; Vallee, Wacker,
Bartholomay and Hoch, 1957). No definite explanation can be offered for the four
elevated serum zinc levels encountered although the hepatomas in these four
patients may have supervened in non-cirrhotic livers. Judged on the findings of
Davies, Musa and Dormandy (1968) in patients with carcinoma of the bronchus,
radiation or cytotoxic drug therapy do not result in elevated plasma zinc con-
centrations. The effects ofsuch treatment in liver carcinoma cases, however, may
not be comparable.
Although the mean serum zinc value (139 Itg.%) in the 31 patients in the present
series is somewhat higher than that of the controls (100.5 jug.%), the difference is
not statistically significant. It therefore seems unlikely that the mean serum
zinc value of 132 jag.0% in the 12 cases reported by Karlinsky and Roomere
(1967) represents a statistically significant increase.
As has recently been pointed out (Lancet, 1968) the status of blood and tissue
zinc in relation to neoplastic disease in general is far from clear and merits further
careful examination.
SUMMIARY
Serum zinc estimations have been performed by means of an atomic absorption
spectrophotometer on 31 Bantu males suffering from primary liver cancer. A
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mean serum zinc value of 139 jug.% was found as compared with a mean of
1005,ug.% in a control group. This difference is not statistically significant.
However, in four of the hepatoma cases elevated values (205 to 350,g.%) were
encountered.
We are grateful to the South African Primary Liver Cancer Research Group
and to Dr. E. W. Geddes and Dr. N. de Moor for allowing us to study patients
under their care; also to the photographic unit of the Department of Medicine
for Fig. 1.
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